Avallano Strengthens Leadership with New Chief Strategy Officer to Drive AI-Powered Clinical Research Innovation
GREENVILLE, S.C. – Avallano, an AI-enabled clinical research company, today announced the appointment of Michael A. Ibara, Pharm.D., as Chief Strategy Officer (CSO). Dr. Ibara will lead the company’s global strategic initiatives to transform the clinical trial sector with leading-edge technology solutions. “I am delighted to join Avallano at such an exciting time in the company’s growth”Post this Dr. Ibara will lead the launch of … Continue reading Avallano Strengthens Leadership with New Chief Strategy Officer to Drive AI-Powered Clinical Research Innovation